Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Amifostine trihydrate (WR2721) is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 31.00 | |
10 mg | In stock | $ 51.00 | |
25 mg | In stock | $ 117.00 | |
50 mg | In stock | $ 176.00 | |
100 mg | In stock | $ 270.00 | |
200 mg | In stock | $ 432.00 | |
500 mg | In stock | $ 716.00 |
Description | Amifostine trihydrate (WR2721) is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin. |
Synonyms | Ethyol trihydrate, WR2721, Amifostine |
Molecular Weight | 268.27 |
Formula | C5H15N2O3PS·3H2O |
CAS No. | 112901-68-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Insoluble
H2O: 10 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Amifostine trihydrate 112901-68-5 Chromatin/Epigenetic Metabolism Others HIF/HIF Prolyl-Hydroxylase DNA-damage thiol HIF-PH cytoprotective Broad-spectrum Hypoxia-inducible factors HIF-α1 Ethyol MDM-2/p53 Ethyol Trihydrate Inhibitor p53 Amifostine Trihydrate Ethyol trihydrate WR-2721 inhibit antiangiogenic WR2721 radioprotector WR 2721 HIFs Amifostine inhibitor